5V5V image
Entry Detail
PDB ID:
5V5V
Keywords:
Title:
Complex of NLGN2 with MDGA1 Ig1-Ig2
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2017-03-15
Release Date:
2017-07-05
Method Details:
Experimental Method:
Resolution:
4.11 Å
R-Value Free:
0.31
R-Value Work:
0.28
R-Value Observed:
0.29
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Neuroligin-2
Chain IDs:A, C (auth: B), D (auth: C), E (auth: D), F (auth: E), G (auth: F)
Chain Length:582
Number of Molecules:6
Biological Source:Rattus norvegicus
Polymer Type:polypeptide(L)
Description:MAM domain-containing glycosylphosphatidylinositol anchor protein 1
Chain IDs:B (auth: G), H, I, J, K, L
Chain Length:230
Number of Molecules:6
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Molecular Mechanism of MDGA1: Regulation of Neuroligin 2:Neurexin Trans-synaptic Bridges.
Neuron 94 1132 1141.e4 (2017)
PMID: 28641112 DOI: 10.1016/j.neuron.2017.06.009

Abstact

Neuroligins and neurexins promote synapse development and validation by forming trans-synaptic bridges spanning the synaptic cleft. Select pairs promote excitatory and inhibitory synapses, with neuroligin 2 (NLGN2) limited to inhibitory synapses and neuroligin 1 (NLGN1) dominating at excitatory synapses. The cell-surface molecules, MAM domain-containing glycosylphosphatidylinositol anchor 1 (MDGA1) and 2 (MDGA2), regulate trans-synaptic adhesion between neurexins and neuroligins, impacting NLGN2 and NLGN1, respectively. We have determined the molecular mechanism of MDGA action. MDGA1 Ig1-Ig2 is sufficient to bind NLGN2 with nanomolar affinity; its crystal structure reveals an unusual locked rod-shaped array. In the crystal structure of the complex, two MDGA1 Ig1-Ig2 molecules each span the entire NLGN2 dimer. Site-directed mutagenesis confirms the observed interaction interface. Strikingly, Ig1 from MDGA1 binds to the same region on NLGN2 as neurexins do. Thus, MDGAs regulate the formation of neuroligin-neurexin trans-synaptic bridges by sterically blocking access of neurexins to neuroligins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures